[HTML][HTML] Implementing New Approach Methodologies (NAMs) in food safety assessments: Strategic objectives and actions taken by the European Food Safety …

I Cattaneo, MC Astuto, M Binaglia, Y Devos… - Trends in Food Science …, 2023 - Elsevier
Abstract Background New Approach Methodologies (NAMs) comprise in silico and in vitro
methods applied as alternative to animal testing. Even though NAMs are already fully …

Drug-drug interactions that alter the exposure of glucuronidated drugs: Scope, UDP-glucuronosyltransferase (UGT) enzyme selectivity, mechanisms (inhibition and …

JO Miners, TM Polasek, JA Hulin, A Rowland… - Pharmacology & …, 2023 - Elsevier
Drug-drug interactions (DDIs) arising from the perturbation of drug metabolising enzyme
activities represent both a clinical problem and a potential economic loss for the …

Development of a roadmap for action on new approach methodologies in risk assessment

SE Escher, F Partosch, S Konzok… - EFSA Supporting …, 2022 - Wiley Online Library
While whole animal studies have their place in risk assessment of food and feed
components, it is thought that more modern approaches such as human focused new …

Inhibition of UDP-glucuronosyltransferase enzymes by major cannabinoids and their metabolites

S Nasrin, CJW Watson, K Bardhi, G Fort, G Chen… - Drug Metabolism and …, 2021 - ASPET
The UDP-glucuronosyltransferase (UGT) family of enzymes play a central role in the
metabolism and detoxification of a wide range of endogenous and exogenous compounds …

[HTML][HTML] Human variability in polymorphic CYP2D6 metabolism: Implications for the risk assessment of chemicals in food and emerging designer drugs

K Darney, LS Lautz, C Béchaux, W Wiecek… - Environment …, 2021 - Elsevier
The major human cytochrome P450 CYP2D6 isoform enzyme plays important roles in the
liver and in the brain with regards to xenobiotic metabolism. Xenobiotics as CYP2D6 …

Drug metabolism of hepatocyte-like organoids and their applicability in in vitro toxicity testing

MC Bouwmeester, Y Tao, S Proença… - Molecules, 2023 - mdpi.com
Emerging advances in the field of in vitro toxicity testing attempt to meet the need for reliable
human-based safety assessment in drug development. Intrahepatic cholangiocyte …

[HTML][HTML] Human variability in glutathione-S-transferase activities, tissue distribution and major polymorphic variants: Meta-analysis and implication for chemical risk …

FM Buratti, K Darney, S Vichi, L Turco, E Di Consiglio… - Toxicology letters, 2021 - Elsevier
The input into the QIVIVE and Physiologically-Based kinetic and dynamic models of drug
metabolising enzymes performance and their inter-individual differences significantly …

Modelling human variability in toxicokinetic and toxicodynamic processes using Bayesian meta‐analysis, physiologically‐based modelling and in vitro systems

E Testai, C Bechaux, FM Buratti… - EFSA Supporting …, 2021 - Wiley Online Library
This external scientific report summarises the results from thearticle 36 grant
GA/EFSA/SCER/2015/01 ″Modelling human variability in toxicokinetic and toxicodynamic …

Stratification of volunteers according to flavanone metabolite excretion and phase ii metabolism profile after single doses of 'pera'orange and 'moro'blood orange …

A Nishioka, EC Tobaruela, LN Fraga… - Nutrients, 2021 - mdpi.com
Large interindividual variations in the biological response to citrus flavanones have been
observed, and this could be associated with high variations in their bioavailability. The aim …

PBPK modeling as a tool for predicting and understanding intestinal metabolism of uridine 5′-Diphospho-glucuronosyltransferase substrates

MB Reddy, MB Bolger, G Fraczkiewicz, L Del Frari… - Pharmaceutics, 2021 - mdpi.com
Uridine 5′-diphospho-glucuronosyltransferases (UGTs) are expressed in the small
intestines, but prediction of first-pass extraction from the related metabolism is not well …